This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2016 05 12 arb WGM"
Jump to navigation
Jump to search
m (→Minutes) |
m (→Minutes) |
||
| Line 15: | Line 15: | ||
#* Finish Substantivity | #* Finish Substantivity | ||
#* Finish withdrawal with PIC | #* Finish withdrawal with PIC | ||
| − | #* Evaluate CIMI architecture | + | #* CIMI |
| − | #* Evaluate CIMI clinical model proof of concept PSS | + | #** Engage with Grahame on CIMI on FHIR |
| + | #** Evaluate CIMI architecture | ||
| + | #** Evaluate CIMI clinical model proof of concept PSS | ||
#* Product Director | #* Product Director | ||
#* ???? | #* ???? | ||
Revision as of 18:49, 12 May 2016
Present
Andy B, Paul, Mario, Tony, Wayne, Patrick, Lorraine
Agenda
- Thursday Q3
- CIMI product family
- Not a new product - the PSS addressed a new set of models.
- ARB opportunity to vet the modeling and methodology.
- Tony will schedule Jay Lyle to join teleconference re PSS.
- Paul: Should we reach out to the rest of CIMI to find out what they are doing.
- Product Director discussion
- SAIF-IG discussion
- Follow up and lessons learned from this meeting.
- CIMI product family
Minutes
- Next Steps
- Finish Substantivity
- Finish withdrawal with PIC
- CIMI
- Engage with Grahame on CIMI on FHIR
- Evaluate CIMI architecture
- Evaluate CIMI clinical model proof of concept PSS
- Product Director
- ????
